INTRODUCTION Many studies conducted in 1950’s and 1960’s suggest that hallucinogen assisted psychedelic psychotherapy may offer an effective treatment.

Slides:



Advertisements
Similar presentations
Chapter 1 (con’t) Psychology & Science
Advertisements

CLINICAL CASE FORMULATION Felícitas Kort Psychology Projects Coordinator Clinical Management Consultants FREEDOM FROM FEAR.
13 Principles of Effective Addictions Treatment
Research Study Designs
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Aftercare Attendance Partially Moderated by History of Physical Abuse and Gender Louise F. Haynes 1 ; Amy E. Herrin 1 ; Rickey E. Carter 1 ; Sudie E. Back.
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Long-term Safety and Effectiveness of Natalizumab STRATA MS Study.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
Addiction UNIT 4: PSYA4 Content The Psychology of Addictive Behaviour Models of Addictive Behaviour  Biological, cognitive and.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Chapter 9 - Lecture 2 Some more theory and alternative problem formats. (These are problem formats more likely to appear on exams. Most of your time in.
Journal Club Alcohol and Health: Current Evidence July-August 2006.
PSY 330 Lect 2 1 What is Science? Science – set of practices and methods to obtain ____________. Its primary aim is to find order and lawful relations.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Chapter 9 - Lecture 2 Computing the analysis of variance for simple experiments (single factor, unrelated groups experiments).
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia? By : s.bruce, PhD et al (Am J Psychiatry.
MMPI (Minnesota Multiphasic Personality Inventory)
Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)
Factors that Influence Retention in Greek Therapeutic Communities Erianna Daliani MSc (Gerasimos Papanastasatos) KETHEA Research Dept. 11th European Conference.
Using Assessment in Counseling
ILLINOIS STATEWIDE TREATMENT OUTCOMES PROJECT. Illinois Statewide Treatment Outcomes Project Largest evaluation of treatment outcomes by the State to.
Copyright © 2007 Pearson Education, Inc. Publishing as Pearson Addison-Wesley Chapter 13 Experiments and Observational Studies.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
American Association for the Treatment of Opioid Dependence, Inc National Conference, Atlanta April 25, 2006 Evaluation of the Impact of Opioid Treatment.
Does reduction in cocaine use represent psychosocial benefit? Ivan D. Montoya, M.D., M.P.H. Deputy Director, NIDA-DPMC.
Exploring Ibogaine’s Potential in the Treatment of Addiction Multidisciplinary Association for Psychedelic Studies (MAPS) Presented.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Alpha-theta The Addicted Brain Drug abuse produces long-term changes in the reward circuitry of the brain.
Slide 13-1 Copyright © 2004 Pearson Education, Inc.
Goldstein (1988) Gottesman & Shields (1966)
The Effectiveness of Psychodynamic Therapy and Cognitive Behavior Therapy in the Treatment of Personality Disorders: A Meta-Analysis. By Falk Leichsenring,
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Evaluating Mental Health System Enhancements Investigators: Heather Stuart, PhD and Terry Krupa, PhD, Queen’s University Research Associate: Michelle Koller,
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Assessment Personality Assessment Clinical Interviews unstructured interview semistructured interview.
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2012.
Exploratory Outcome Study of Ibogaine-Assisted Therapy in 20 Chemically-Dependent Persons Valerie Mojeiko Multidisciplinary Association for Psychedelic.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Marion Oliver Educ 709.  It is of incredible importance to students’ connection to school, as well as their ability and desire to stay in school (McNeely.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Augmentation of Exposure-Based Cognitive Behavioral Therapy with D-cycloserine in Patients with Panic Disorder Sean Donovan, Meenakshi Shelat, Corrinne.
MMPI-2. What Does the MMPI-2 Test? 1.Hypochondriasis (Hs) – The Hypochondriasis scale tapes a wide variety of vague and nonspecific complaints about bodily.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
How to Read a Journal Article. Basics Always question: – Does this apply to my clinical practice? – Will this change how I treat patients? – How could.
Psychological Therapies Schizophrenia. Introduction Although the use of drugs is crucial in the treatment of schizophrenia, many people do not experience.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Abnormal Functional Brain Connectivity and Personality.
Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,
All analyses below measured the relationship between MMPI-2 cluster groups and discharge outcome scores. Analyses were conducted separately for male and.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Introduction.
Krzysztof Rutkowski Edyta Dembińska Department of Psychotherapy,
Assessment of Abnormal Behavior
Assessment of Abnormal Behavior
More Diagnostic Testing: The MMPI, the MCMI, and MMSE
Using the MMPI-A to Identify Students with Emotional Disturbance
Clinical Assessment and Diagnosis
Systems of Classification
Presentation transcript:

INTRODUCTION Many studies conducted in 1950’s and 1960’s suggest that hallucinogen assisted psychedelic psychotherapy may offer an effective treatment for alcoholism and addictions. However, different and not a rigorous scientific methodologies make it difficult to generalize across studies.

Ketamine has several advantages over other psychedelics as an adjunct to psychotherapy: Safe Short acting Not scheduled as other psychedelics Allowed for general anesthesia In our previous studies it has been shown to be an effective treatment for alcoholism

New approaches to treatment of heroin addiction in Russia are particularly important because of: Epidemic of heroin addiction since mid-1990s All agonists (methadone, LAAM) and partial agonists-antagonists (buprenorphine) are prohibited by the law HIV epidemic among heroin addicts

Seventy detoxified heroin addicts were randomly assigned to one of two groups: §The patients of the experimental group received psychotherapy in combination with a “psychedelic” dose of ketamine (2.0 mg/kg i.m.) §The patients of the control group received the same psychotherapy combined with a very low, non-psychedelic (non-hallucinogenic), dose of ketamine (0.20 mg/kg i.m.)  Both the psychotherapist and subject were blind to the dose of ketamine Study design

Assessments. Psychiatric symptoms:

Psychological Assessments:

Treatment Assessment, Outcome and Follow-up:

Treatment Procedure:

Data Management and Statistical Analysis:

0,00 0,50 1,00 1,50 2,00 2,50 IntensitySomaesthesiaAffectPerceptionCognitionVolition High dose Low dose Characteristics of ketamine experience with HRS *** ** ***

+

0,00 2,00 4,00 6,00 8,00 10,00 12,00 14,00 16,00 Before KPT High dose After KPT High dose Before KPT Low dose After KPT Low dose Affective subscale Cognitive subscale Behavioral subscale KPT influence on the syndrome of anhedonia

0,00 10,00 20,00 30,00 40,00 50,00 60,00 70,00 80,00 Lie (L) Validity (F) Correction (K) Hypochondriasis (Hs) Depression (D) Convertion hysteria (Hy) Psychopathic deviate (Pd) Masculinity-femininity (Mf) Paranoia (Pa) Psychastenia (Pt) Schizophrenia (Sc) Hypomania (Ma) Social introversion (Si) Iowa manifest anxiety (Tailor) (At) Sensitivity-Repression (S-R) Ego strength (Es) Self-sufficiency (Sf) High dose Before KPT High dose After KPT KPT influence on the Minnesota Multiphasic Personality Inventory

0,00 10,00 20,00 30,00 40,00 50,00 60,00 70,00 80,00 90,00 Lie (L) Validity (F) Correction (K) Hypochondriasis (Hs) Depression (D) Convertion hysteria (Hy) Psychopathic deviate (Pd) Masculinity-femininity (Mf) Paranoia (Pa) Psychastenia (Pt) Schizophrenia (Sc) Hypomania (Ma) Social introversion (Si) Iowa manifest anxiety (Tailor) (At) Sensitivity-Repression (S-R) Ego strength (Es) Self-sufficiency (Sf) Low dose Before KPT Low dose After KPT KPT influence on the Minnesota Multiphasic Personality Inventory

0,00 10,00 20,00 30,00 40,00 50,00 60,00 70,00 80,00 90,00 100,00 Index of the understanding of the meaning of lifeUnderstanding of purposes in life Meaning of the process of life Self- actualization Locus of control of self Locus of control of life High dose Before KPT High dose After KPT Low dose Before KPT Low dose After KPT KPT influence on the purposes in life * * * * * * * ** * * *

* * * ** * * * ** *

Side effects and complications:

Psychedelic afterglow §One of the insights gained from previous research with psychedelics concerns the transient psychotherapeutic and psychological effects of psychedelic psychotherapy. The effects of psychedelic psychotherapy are often very pronounced within several days or weeks after a treatment session, but then these effects quickly decline. This phenomenon was termed a “psychedelic afterglow.”

Previous KPT study: §About 50% of patients in a high ketamine dose group and 60% of patients in a low dose group relapsed within the first 3 months.

Hypothesis: §Could the efficacy of KPT in treating heroin dependence be increased by administering multiple KPT sessions and thus stabilizing the afterglow?

Study design: §In this study of the efficacy of single versus repeated sessions of ketamine-assisted psychotherapy in promoting abstinence in people with heroin dependence, 59 detoxified inpatients with heroin dependence received a ketamine- assisted psychotherapy (KPT) session prior to their discharge from an addiction treatment hospital, and were then randomized into two treatment groups: 1.Participants in the first group received two addiction counseling sessions followed by two KPT sessions, with sessions scheduled on a monthly interval (multiple KPT group). 2.Participants in the second group received two addiction counseling sessions on a monthly interval, but no additional ketamine therapy sessions (single KPT group).

Study design II: §All participants were treated alike and were given the same preparation for KPT. The KPT sessions, regardless of their number, were given under uniform circumstances at the same psychiatric hospital. Clinical evaluators blind to whether participants had received one or three KPT sessions performed psychological and clinical evaluations on all participants during treatment and follow-up periods.

Drop out: §Six out of 59 participants enrolled in the study relapsed and dropped out of treatment within the first month after the initial KPT session. Prior to the second session, the 53 remaining participants were randomized into the two treatment groups: § Twenty-six participants were assigned to the multiple KPT group and received two more KPT sessions, including addiction counseling sessions before KPT, separated by one-month intervals. §Twenty-seven participants were assigned to the single KPT group and received two addiction counseling sessions separated by one-month intervals. There were no statistically significant differences between these groups in the mean age, duration of heroin addiction, and gender.

Retention in Treatment: §In the multiple KPT group, four out of 26 participants (15.4%) relapsed and dropped out of treatment after the second KPT session but prior to the third. §In the single KPT group, seven out of 27 participants (25.9%) relapsed and dropped out of treatment after the first counseling session. §The difference in the retention in treatment phase between the two groups was not statistically significant.

Kaplan-Meier Survival Analysis P<0.01 Months Cummulative Survival 1,2 1,0,8,6,4,2 0,0 Group of treatment Single KPT session single-censored Multiple KPT sessions multiple-censored

Kaplan-Meier Survival Analysis P<0.01

Rate of Abstinence: §At the end of the one-year follow-up, 13 out of 26 participants (50%) in the multiple KPT group remained abstinent compared to six out of 27 participants (22.2%) in the single KPT group (p < 0.05).

Conclusion § Three sessions of ketamine-assisted psychotherapy are more effective than a single session for the treatment of heroin addiction.

What does all of that mean?

Should we take a courage to bridge the gap between psychedelic psychotherapy and main stream?

Even though we can not do that right now…

We should start to go this way…

Think more about that…

Balance all the arguments…

Be very careful with every tiny detail…

THE FUTURE ?

Some men see things as they are, and say “why?” I dream of things that have never been, and say “why not?” Robert F Kennedy